% | $
Quotes you view appear here for quick access.

VIVUS Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • todzun todzun Nov 15, 2012 10:19 AM Flag

    stupid longs still think this crap is going up

    It is going up, 3000 plus physicians now prescribing Qsymia, 60 million obese in the US alone. 80 to 90 % of trial participants happy with results and stayed on Qsymia for the length of the clinical trial. Q4 results to confirm.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Let's put all the bashing and insults aside and just look at the numbers based on Vivus last conference call. They have a very expensive REMS process to fund without a partner. This will burn their cash very quickly. Until they show the finacial community clarity on how Qsymia will generate the revenue required, or they announce a partner (nothing on the horizon there), this will be a very risky investment. Expect a secondary next quarter if they can even pull one off.

      Sentiment: Strong Sell

      • 1 Reply to i_p_day_lee
      • Yes, let's look the numbers, 3000 physicians now prescribing Qsymia, 300 million in cash and cash eq. $17 million of the 40 million spent in Q3 was for inventory. Don't expect a secondary anytime soon. Partnership may come at anytime if the price is right for VVUS. Modified REMs in a few months. Direct advertising can start in July 2013.

1.12+0.02(+1.82%)4:00 PMEDT